Olivier Schwartz

69PUBLICATIONS
476CO-AUTHORS
Innate immunityBiologically active moleculesMedical infection agents (incl. prions)Medical virologyChemical engineering design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (69)

|May 15, 2026
Variability in the TLR3 type I interferon pathway is predictive of RNA vaccine responses.

|Mar 24, 2026
DNA-PK interacts with cyclic dinucleotides and inhibits type I interferon responses.

Isabelle K Vila, Yasmine Messaoud-Nacer, Clara Taffoni

|Dec 10, 2025
Potent neutralization by antibodies targeting the MPXV A28 protein.

Ron Yefet, Leandro Battini, Mathieu Hubert

|Dec 10, 2025
Antigen-agnostic identification of poxvirus broadly neutralizing antibodies targeting OPG153.

Ida Paciello, Emily J Rundlet, Ling Zhou

|Nov 21, 2025
Targeting ACE2 with a camelid antibody inhibits SARS-CoV-2 binding and has protective effects in vivo.

Simon Blachier, Marie-Christine Vaney, Laurine Conquet

|Feb 12, 2025
Structural insights into tecovirimat antiviral activity and poxvirus resistance.

Riccardo Vernuccio, Alejandro Martínez León, Chetan S Poojari

Pageof 12

Frequent Collaborators

21 joint publications

Timothée Bruel

17 joint publications

Julian Buchrieser

15 joint publications

Françoise Porrot

13 joint publications

Etienne Simon-Lorière